Clark Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Sell
8,533
-195
-2% -$15.7K 0.38% 41
2026
Q1
$762K Buy
8,728
+291
+3% +$27.9K 0.51% 27
2025
Q4
$810K Hold
8,437
0.49% 28
2025
Q3
$810K Buy
8,437
+1,204
+17% +$111K 0.49% 28
2025
Q2
$631K Sell
7,233
-352
-5% -$29.9K 0.43% 36
2025
Q1
$682K Buy
7,585
+649
+9% +$58.1K 0.51% 30
2024
Q4
$554K Buy
+6,936
New +$600K 0.43% 35

Other funds holding MDT

Clark Wealth Partners's MDT Position: Q2 2026 in Review

Clark Wealth Partners reduced its Medtronic (MDT) stake by 2.2% in Q2 2026, selling an estimated $15.7K and leaving 8,533 shares worth $674K. The position accounts for 0.38% of the portfolio, ranked #41.

Clark Wealth Partners first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $810K in Q4 2025. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Clark Wealth Partners held 8,533 shares of Medtronic worth $674K as of Q2 2026.
  • Clark Wealth Partners sold 195 Medtronic shares in Q2 2026, an estimated $15.7K.
  • Medtronic made up 0.38% of Clark Wealth Partners's portfolio in Q2 2026, its #41 holding.
  • Clark Wealth Partners first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Clark Wealth Partners's Medtronic position peaked at $810K in Q4 2025.
  • 2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.